Clinical Trial Update: A Study of Extended Carfilzomib Therapy for Patients Previously Enrolled in Carfilzomib Treatment Protocols [Phase 2]

View source ↗

Summary

A Phase 2 study evaluated extending carfilzomib therapy in patients previously enrolled in carfilzomib treatment protocols. The trial has completed, and results…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple Myeloma
• Solid Tumors

Drugs mentioned

• Kyprolis (carfilzomib)

Snippet

Sponsor: Amgen | Conditions: Multiple Myeloma, Solid Tumors | Phase 2 | Status: COMPLETED | Results posted: 2018-05-14